Biomarkers in Duchenne Muscular Dystrophy.

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration.
• Identifying reliable biomarkers is crucial for diagnosis, tracking disease progression, and evaluating therapeutic interventions.

Purpose of the Study:

• To review current research on biomarkers for Duchenne muscular dystrophy.
• To highlight findings from proteomic and metabolomic studies in DMD patients and animal models.

Main Methods:

• Literature review of key studies on DMD biomarkers.
• Analysis of proteomic and metabolomic data from human and animal studies.

Main Results:

• Various potential biomarkers have been identified through proteomic and metabolomic analyses.
• These studies have been conducted in both human Duchenne muscular dystrophy patients and relevant animal models.

Conclusions:

• Proteomic and metabolomic approaches have identified promising biomarkers for Duchenne muscular dystrophy.
• Further rigorous studies in DMD patients are essential to validate these biomarkers for clinical applications, including diagnosis, monitoring disease progression, and assessing treatment efficacy.